Found: 133
Select item for more details and to access through your institution.
Pipeline for specific subtype amplification and drug resistance detection in hepatitis C virus.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Enhancing linkage to care for hepatitis B, D, and C patients: A retrospective‐prospective study.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 60, n. 10, p. 1308, doi. 10.1111/apt.18227
- By:
- Publication type:
- Article
Hepatitis-C-Related Hepatocellular Carcinoma, Still a Relevant Etiology beyond a Hepatitis C Infection Cure.
- Published in:
- Cancers, 2024, v. 16, n. 8, p. 1521, doi. 10.3390/cancers16081521
- By:
- Publication type:
- Article
Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: The Preblin study.
- Published in:
- PLoS ONE, 2017, v. 12, n. 9, p. 1, doi. 10.1371/journal.pone.0184550
- By:
- Publication type:
- Article
Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response.
- Published in:
- PLoS ONE, 2017, v. 12, n. 1, p. 1, doi. 10.1371/journal.pone.0168713
- By:
- Publication type:
- Article
Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B.
- Published in:
- Digestive Diseases & Sciences, 2023, v. 68, n. 6, p. 2731, doi. 10.1007/s10620-022-07817-w
- By:
- Publication type:
- Article
Correction to: Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a: Week 120 Analysis.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Seven-Year Efficacy and Safety of Treatment with Tenofovir Disoproxil Fumarate for Chronic Hepatitis B Virus Infection.
- Published in:
- Digestive Diseases & Sciences, 2015, v. 60, n. 5, p. 1457, doi. 10.1007/s10620-014-3486-7
- By:
- Publication type:
- Article
Viral Suppression and Cirrhosis Regression with Tenofovir Disoproxil Fumarate in Asians with Chronic Hepatitis B.
- Published in:
- Digestive Diseases & Sciences, 2015, v. 60, n. 1, p. 260, doi. 10.1007/s10620-014-3336-7
- By:
- Publication type:
- Article
Long-term immunogenicity and efficacy of hepatitis B vaccine in hemodialysis patients.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management.
- Published in:
- Therapeutic Advances in Gastroenterology, 2021, v. 14, p. 1, doi. 10.1177/17562848211016563
- By:
- Publication type:
- Article
Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Quantitative Hepatitis B Virus DNA Testing for the Early Prediction of the Maintenance of Response during Lamivudine Therapy in Patients with Chronic Hepatitis B.
- Published in:
- Journal of Infectious Diseases, 2001, v. 183, n. 8, p. 1277, doi. 10.1086/319677
- By:
- Publication type:
- Article
Influence of Human Immunodeficiency Virus Infection on Cell-Mediated Immunity in Chronic D Hepatitis.
- Published in:
- Journal of Infectious Diseases, 1991, v. 163, n. 6, p. 1351, doi. 10.1093/infdis/163.6.1351
- By:
- Publication type:
- Article
In-Host Flat-like Quasispecies: Characterization Methods and Clinical Implications.
- Published in:
- Microorganisms, 2024, v. 12, n. 5, p. 1011, doi. 10.3390/microorganisms12051011
- By:
- Publication type:
- Article
Community Strategy for Hepatitis B, C, and D Screening and Linkage to Care in Mongolians Living in Spain.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 7, p. 1506, doi. 10.3390/v15071506
- By:
- Publication type:
- Article
Global Real-World Evidence of Sofosbuvir/Velpatasvir as a Highly Effective Treatment and Elimination Tool in People with Hepatitis C Infection Experiencing Mental Health Disorders.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 11, p. 2493, doi. 10.3390/v14112493
- By:
- Publication type:
- Article
Inspecting the Ribozyme Region of Hepatitis Delta Virus Genotype 1: Conservation and Variability.
- Published in:
- Viruses (1999-4915), 2022, v. 14, n. 2, p. 215, doi. 10.3390/v14020215
- By:
- Publication type:
- Article
Natural History and Management of Hepatitis C: Does Sex Play a Role?
- Published in:
- Journal of Infectious Diseases, 2014, v. 209, n. suppl_3, p. S81, doi. 10.1093/infdis/jiu057
- By:
- Publication type:
- Article
Hepatitis B Virus Variants with Multiple Insertions and/or Deletions in the X Open Reading Frame 3′ End: Common Members of Viral Quasispecies in Chronic Hepatitis B Patients.
- Published in:
- Biomedicines, 2022, v. 10, n. 5, p. 1194, doi. 10.3390/biomedicines10051194
- By:
- Publication type:
- Article
Large-scale viral genome analysis identifies novel clinical associations between hepatitis B virus and chronically infected patients.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-46609-7
- By:
- Publication type:
- Article
The impact of COVID-19 on the cascade of care of HCV in the US and China.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2022, v. 27, n. 3, p. 1, doi. 10.1016/j.aohep.2022.100685
- By:
- Publication type:
- Article
Sclerosing Cholangitis Related to IgG4: Not Always a Curable Entity.
- Published in:
- Annals of Hepatology: Official Journal of the Mexican Association of Hepatology, 2019, v. 18, n. 1, p. 215, doi. 10.5604/01.3001.0012.7916
- By:
- Publication type:
- Article
Thrombotic thrombocytopenic purpura relapse induced by acute hepatitis E transmitted by cryosupernatant plasma and successfully controlled with ribavirin.
- Published in:
- 2018
- By:
- Publication type:
- case study
Red blood cell transfusion-transmitted acute hepatitis E in an immunocompetent subject in Europe: a case report.
- Published in:
- 2017
- By:
- Publication type:
- case study
Paracetamol in therapeutic dosages and acute liver injury: causality assessment in a prospective case series.
- Published in:
- 2011
- By:
- Publication type:
- journal article
A simple dummy liver assist device prolongs anhepatic survival in a porcine model of total hepatectomy by slight hypothermia.
- Published in:
- BMC Gastroenterology, 2011, v. 11, n. 1, p. 79, doi. 10.1186/1471-230X-11-79
- By:
- Publication type:
- Article
The elimination of hepatitis D as a public health problem: Needs and challenges.
- Published in:
- Journal of Viral Hepatitis, 2024, v. 31, n. 1, p. 47, doi. 10.1111/jvh.13891
- By:
- Publication type:
- Article
Clinical and patient‐reported outcome profile of patients with hepatitis B viral infection from the Global Liver Registry™.
- Published in:
- Journal of Viral Hepatitis, 2023, v. 30, n. 4, p. 335, doi. 10.1111/jvh.13800
- By:
- Publication type:
- Article
Severe impairment of patient-reported outcomes in patients with chronic hepatitis C virus infection seen in real-world practices across the world: Data from the global liver registry.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 11, p. 1015, doi. 10.1111/jvh.13741
- By:
- Publication type:
- Article
Cost‐effectiveness analysis of an active search to retrieve HCV patients lost to follow‐up (RELINK‐C strategy) and the impact of COVID‐19.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 7, p. 579, doi. 10.1111/jvh.13686
- By:
- Publication type:
- Article
Point‐of‐care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination.
- Published in:
- Journal of Viral Hepatitis, 2022, v. 29, n. 3, p. 227, doi. 10.1111/jvh.13634
- By:
- Publication type:
- Article
Resistance‐associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 9, p. 1319, doi. 10.1111/jvh.13497
- By:
- Publication type:
- Article
Estimating the attributable fraction of cirrhosis and hepatocellular carcinoma due to hepatitis B and C.
- Published in:
- Journal of Viral Hepatitis, 2021, v. 28, n. 8, p. 1177, doi. 10.1111/jvh.13545
- By:
- Publication type:
- Article
Unexpected long‐lasting anti‐HEV IgM positivity: Is HEV antigen a better serological marker for hepatitis E infection diagnosis?
- Published in:
- Journal of Viral Hepatitis, 2020, v. 27, n. 7, p. 747, doi. 10.1111/jvh.13285
- By:
- Publication type:
- Article
Efficacy and safety of a two‐drug direct‐acting antiviral agent regimen ruzasvir 180 mg and uprifosbuvir 450 mg for 12 weeks in adults with chronic hepatitis C virus genotype 1, 2, 3, 4, 5 or 6.
- Published in:
- Journal of Viral Hepatitis, 2019, v. 26, n. 9, p. 1127, doi. 10.1111/jvh.13132
- By:
- Publication type:
- Article
Hepatitis E Virus Epidemiology in Industrialized Countries.
- Published in:
- Emerging Infectious Diseases, 2003, v. 9, n. 4, p. 448, doi. 10.3201/eid0904.020351
- By:
- Publication type:
- Article
Drugs in Development for Hepatitis B.
- Published in:
- Drugs, 2005, v. 65, n. 11, p. 1451, doi. 10.2165/00003495-200565110-00001
- By:
- Publication type:
- Article
Hepatitis B Surface Antigen Levels Can Be Used to Rule Out Cirrhosis in Hepatitis B e Antigen-Positive Chronic Hepatitis B: Results From the SONIC-B Study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis B.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Tenofovir Alafenamide Fumarate: A New Tenofovir Prodrug for the Treatment of Chronic Hepatitis B Infection.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Increasing and sustaining blood-borne virus screening in Spain and Portugal throughout the COVID-19 pandemic: a multi-center quality improvement intervention.
- Published in:
- Frontiers in Public Health, 2024, p. 1, doi. 10.3389/fpubh.2023.1268888
- By:
- Publication type:
- Article
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-53310-x
- By:
- Publication type:
- Article
An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor‐induced liver injury.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 7, p. 865, doi. 10.1111/apt.17898
- By:
- Publication type:
- Article
Editorial: Liver elastography for chronic hepatitis D—the end of liver biopsy?
- Published in:
- 2024
- By:
- Publication type:
- Editorial
Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeks.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 2, p. 217, doi. 10.1111/apt.17764
- By:
- Publication type:
- Article
Hepatitis B virus haplotype number at baseline is a predictive marker of functional cure during antiviral therapy for patients with genotypes A and D HBeAg‐positive chronic hepatitis B.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2023, v. 57, n. 5, p. 509, doi. 10.1111/apt.17299
- By:
- Publication type:
- Article
Editorial: pegylated interferon combined with bulevirtide for chronic hepatitis delta—new life for an old timer?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Three-Year Efficacy and Safety of Tenofovir Alafenamide Compared to Tenofovir Disoproxil Fumarate in Chronic Hepatitis B Patients.
- Published in:
- Gut & Liver, 2019, v. 13, n. 6(suppl. 1), p. 26
- By:
- Publication type:
- Article